The Age
·general
·2 hours ago
Perth biotech at cutting edge of the future of medicine
Syngenis Laboratories in Perth is set to construct Australia's first commercial Good Manufacturing Practice laboratory for synthetic oligonucleotides. The facility will enable local production of human-grade DNA and RNA, which could bring back approximately $160 million in research work currently overseas. This development promises to enhance intellectual property control and reduce turnaround times for local biotech researchers.
Summary by Glance · The Age
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI